Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
Due to the lack of an effective therapeutic treatment to flavivirus, dengue virus (DENV) nonstructural protein 1 (NS1) has been considered to develop a vaccine owing to its lack of a role in antibody-dependent enhancement (ADE). However, both NS1 and its antibody have shown cross-reactivity to host...
Saved in:
Main Author: | Sootichote R. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/82331 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Dengue and Zika Virus Cross-Reactive Human Monoclonal Antibodies Protect against Spondweni Virus Infection and Pathogenesis in Mice
by: Vanessa Salazar, et al.
Published: (2020) -
Therapeutic and protective efficacy of a dengue antibody against Zika infection in rhesus monkeys
by: Peter Abbink, et al.
Published: (2019) -
Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy
by: Alex W. Wessel, et al.
Published: (2020) -
Modulation of Dengue/Zika Virus pathogenicity by antibody-dependent enhancement and strategies to protect against enhancement in Zika Virus infection
by: Rekha Khandia, et al.
Published: (2019) -
Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections
by: Kam, Yiu-Wing, et al.
Published: (2018)